Clinical trial
A Prospective Clinical Study on the Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening
NCT03911323 is registered in ClinicalTrials.gov with Shenzhen Second People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Clinical Study on the Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening
- Lead sponsor
- Shenzhen Second People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2018
- Completion date
- October 1, 2020
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.